These findings more closely parallel those of another MVP study that excluded patients with severe pre-existing renal dysfunction and examined the effects of APOL1 genotypes on outcomes among patients hospitalized with COVID-19 infections. This evidence concerns the gene APOL1 and Abnormal renal physiology.